MCRI

• MELBOURNE, Jan 16, 2024 - (ACN Newswire) - Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced financing of US$21 million in equity and debt financing.
• The round, led by Singapore-based SPRIM Global Investments (SGI), will help the company prepare for a Phase 3 clinical investigation of the company's PRT120 oral therapy for peanut allergy.
• "SPRIM brings valuable expertise, capabilities and an international investment network to Prota's technology and clinical program," said Prota Executive Chairman Kelly Constable.
• "This partnership and funding will accelerate Prota's drug development plans and clinical trial program, and we look forward to this strategic collaboration as Prota moves toward its Phase 3 trial."

RENO, Nev., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Monarch Casino & Resort, Inc. (NASDAQ: MCRI) announced today that it will release its 2023 third quarter financial results after the market closes on Wednesday, October 18, 2023.

• This cutting-edge app harnesses Weyo's proprietary Augmented Reality (AR) technology to bridge the gap in early childhood education.
• MELBOURNE, Australia, June 28, 2023 /PRNewswire-PRWeb/ -- Prepare for a game-changing learning experience with Weyo: Kids Reading & Learning.
• All activities within the Weyo: Kids Reading & Learning app remain confined within the app, maintaining a secure learning environment.
• Here, Weyo emerges as a beacon of change, delivering superior Pre-K education to all children, regardless of location or socio-economic status.

• The one-time cash dividend is payable on March 15, 2023, to stockholders of record on March 1, 2023.
• As such, for all of calendar year 2023, the Company expects to pay total cash dividends of $5.90 per share.
• John Farahi, Co-Chairman and Chief Executive Officer of Monarch, commented, “The Board of Directors’ authorization of a one-time cash dividend and the initiation of a recurring annual cash dividend highlights the free cash flow generated by our two market-leading properties and our commitment to enhance stockholder value.
• The Company may use borrowings from the Fifth Amended Credit Facility towards a partial payment of the one-time cash dividend and for general corporate purposes.